Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
Advanced Materials (Deerfield Beach, Fla.)|January 31, 2022
Transforming the Chemical Structure and Bio-Nano Activity of Doxorubicin by Ultrasound for Selective Killing of Cancer CellsSukhvir Kaur Bhangu, Soraia Fernandes, Giovanni Luca Beretta, et al.
Biophysical Journal|May 26, 2016
Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk MeasurementsDomenico Salerno, Giovanni L Beretta, Giuliano Zanchetta, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
Photochemical internalization: a new tool for drug deliveryKristian Berg, Marco Folini, Lina Prasmickaite, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancerAlessia Lopergolo, Valentina Nicolini, Enrica Favini, et al.
Biochemical Pharmacology|January 21, 2015
Targeting the invasive phenotype of cisplatin-resistant non-small cell lung cancer cells by a novel histone deacetylase inhibitorValentina Zuco, Giuliana Cassinelli, Giacomo Cossa, et al.
Bioorganic & Medicinal Chemistry|June 19, 2016
Synthetic sulfoglycolipids targeting the serine-threonine protein kinase AktBarbara Costa, Milind Dangate, Maria Vetro, et al.
Anticancer Research|September 4, 2020
New Imidazo[2,1-<i>b</i>][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal MesotheliomaGiovanna Li Petri, Camilla Pecoraro, Ornella Randazzo, et al.
International Journal of Cancer|March 21, 2014
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomasRoberta Zappasodi, Alessandra Cavanè, Marilena V Iorio, et al.
Nucleic Acids Research|February 13, 2025
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levelsBeatrice Tosoni, Eisa Naghshineh, Irene Zanin, et al.
Journal of Translational Medicine|May 22, 2026
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic targetValentina Doldi, Chiara Maura Ciniselli, Claudia Aurelio, et al.
Pageof 24